Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinya Unai is active.

Publication


Featured researches published by Shinya Unai.


Journal of Cardiac Surgery | 2013

Sternal Wound Infection Caused by Mycobacterium chelonae

Shinya Unai; Joseph Miessau; Pawel Karbowski; Gurjyot Bajwa; Hitoshi Hirose

Sternal wound infection caused by Mycobacterium chelonae, a member of the rapidly growing nontuberculous mycobacteria (NTM), is rare and may present without signs and symptoms of systemic infection.


Respiratory Care | 2013

Caution for Anabolic Androgenic Steroid Use: A Case Report of Multiple Organ Dysfunction Syndrome

Shinya Unai; Joseph Miessau; Pawel Karbowski; Michael Baram; Nicholas C. Cavarocchi; Hitoshi Hirose

We report a 42-year-old male amateur body builder and user of anabolic androgenic steroids, who developed ARDS, acute kidney injury, and refractory supraventricular tachycardia. He required extracorporeal membrane oxygenation, continuous veno-venous hemodialysis, and catheter ablation. We believe that long-term anabolic androgenic steroid abuse predisposed the patient to multiple organ dysfunction syndrome, from its immunomodulatory effects in an otherwise healthy patient. Anabolic androgenic steroid use should be part of the history taking process, since it may complicate diagnosis, disease progression, and prognosis.


Artificial Organs | 2016

Acute Myocardial Infarction Complicated by Cardiogenic Shock: An Algorithm-Based Extracorporeal Membrane Oxygenation Program Can Improve Clinical Outcomes.

Shinya Unai; Daizo Tanaka; Nicholas Ruggiero; Hitoshi Hirose; Nicholas C. Cavarocchi

Extracorporeal membrane oxygenation (ECMO) in our institution resulted in near total mortality prior to the establishment of an algorithm-based program in July 2010. We hypothesized that an algorithm-based ECMO program improves the outcome of patients with acute myocardial infarction complicated with cardiogenic shock. Between March 2003 and July 2013, 29 patients underwent emergent catheterization for acute myocardial infarction due to left main or proximal left anterior descending artery occlusion complicated with cardiogenic shock (defined as systolic blood pressure <90 mm Hg despite multiple inotropes, with or without intra-aortic balloon pump, lactic acidosis). Of 29 patients, 15 patients were treated before July 2010 (Group 1, old program), and 14 patients were treated after July 2010 (Group 2, new program). There were no significant differences in the baseline characteristics, including age, sex, coronary risk factors, and left ventricular ejection fraction between the two groups. Cardiopulmonary resuscitation prior to ECMO was performed in two cases (13%) in Group 1 and four cases (29%) in Group 2. ECMO support was performed in one case (6.7%) in Group 1 and six cases (43%) in Group 2. The 30-day survival of Group 1 versus Group 2 was 40 versus 79% (P = 0.03), and 1-year survival rate was 20 versus 56% (P = 0.01). The survival rate for patients who underwent ECMO was 0% in Group 1 versus 83% in Group 2 (P = 0.09). In Group 2, the mean duration on ECMO was 9.8 ± 5.9 days. Of the six patients who required ECMO in Group 2, 100% were successfully weaned off ECMO or were bridged to ventricular assist device implantation. Initiation of an algorithm-based ECMO program improved the outcomes in patients with acute myocardial infarction complicated by cardiogenic shock.


Perfusion | 2015

Veno-venous extracorporeal membrane oxygenation using a double-lumen bi-caval cannula for severe respiratory failure post total artificial heart implantation

Joseph Miessau; Qiong Yang; Shinya Unai; Jwc Entwistle; Nicholas C. Cavarocchi; Hitoshi Hirose

We report a unique utilization of a double-lumen, bi-caval Avalon cannula for veno-venous (VV) extracorporeal membrane oxygenation (ECMO) during placement of a total artificial heart (TAH, SynCardia, Tucson, AZ). A 22-year-old female with post-partum cardiomyopathy was rescued on veno-arterial (VA) ECMO because of cardiogenic shock. The inability to wean ECMO necessitated implantation of the TAH as a bridge to transplant. In addition, the patient continued to have respiratory failure and concomitant VV ECMO was planned with the implant. During TAH implantation, the Avalon cannula was placed percutaneously from the right internal jugular vein into the inferior vena cava (IVC) under direct vision while the right atrium was open. During VV ECMO support, adequate flows on both ECMO and TAH were maintained without adverse events. VV ECMO was discontinued, without reopening the chest, once the patient’s respiratory failure improved. However, the patient subsequently developed a profound respiratory acidosis and required VV ECMO for CO2 removal. The Avalon cannula was placed in the femoral vein to avoid accessing the internal jugular vein and risking damage to the TAH. The patient’s oxygenation eventually improved and the cannula was removed at the bedside. The patient was supported for 22 days on VV ECMO and successfully weaned from the ventilator prior to her orthotropic heart transplantation.


World Journal of Clinical Cases | 2014

Surgical removal of a large mobile left ventricular thrombus via left atriotomy

Daizo Tanaka; Shinya Unai; James T. Diehl; Hitoshi Hirose

Left ventricular (LV) thrombus is a life-threatening complication of severe LV dysfunction. Ventriculotomy has been a commonly performed procedure for LV thrombus; however, it often further decrease LV function after surgery. We present an alternative approach to thrombectomy in order to minimize the postoperative LV dysfunction. A 37-year-old female with a postpartum cardiomyopathy found to have poor LV function and a large left ventricular apical thrombus (3 cm × 3 cm) attached to the apex by a narrow stalk. Given her severe LV dysfunction, the LV thrombus was approached via left atriotomy under cardiopulmonary bypass. The LV thrombus was easily extracted with gentle traction via the mitral valve. Postoperatively, the patient was discharged home without any embolization event or inotropic support. LV thrombectomy via left atriotomy through the mitral valve could be an alternative option for the patients with poor LV function with a mobile LV thrombus.


World Journal of Clinical Cases | 2014

Resolution of hemolysis from pump thrombus during left ventricular assist device exchange

Shinya Unai; Hitoshi Hirose; John W. Entwistle; Louis E. Samuels

A 50-year-old male who underwent a HeartMate II left ventricular assist device placement for ischemic cardiomyopathy presented with discolored urine and hemolysis 3 mo after the operation. His hemolysis was thought to be due to thrombosis within the pump. Imaging studies were not able to visualize a left ventricular thrombus. Medical management with anticoagulation failed and he underwent surgery for a pump exchange. Intraoperatively, a firm thrombus was found within the pump of the HeartMate II, and the color of the urine changed dramatically from cola-colored to yellow which enabled us to confirm the diagnosis.


Asaio Journal | 2017

Quality of Life and Mid-term Survival of Patients Bridged with Extracorporeal Membrane Oxygenation to Left Ventricular Assist Device.

Shinya Unai; Kentaro Yamane; Daizo Tanaka; Gary Cook; Hitoshi Hirose; Nicholas C. Cavarocchi; John W. Entwistle

Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management. However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown. Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD. Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group). No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2–4 patients (primary LVAD group). Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group). Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole. The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38). The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group. Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO.


Journal of Cardiac Surgery | 2014

Robotically Assisted Repair of Double-Orifice Mitral Valve for Mitral Regurgitation

Mark Balceniuk; Shinya Unai; Bajwa Gurjyot

We report a 62‐year‐old female who required surgery for severe mitral regurgitation. Under robotic assistance, the valve was repaired by transection of the fibrous bridge, implantation of four neo‐chordaes to the anterior leaflet, commissuroplasty of the posterolateral commissure, and annuloplasty. doi: 10.1111/jocs.12328 (J Card Surg 2014;29:567–568)


Heart Surgery Forum | 2014

Two-vessel off-pump coronary artery bypass grafting by left thoracotomy in a complex reoperative case.

Shinya Unai; Gary Cook; Hitoshi Hirose; Nicholas C. Cavarocchi; John W. Entwistle

An 83-year-old male with a history of three prior sternotomies, including coronary artery bypass surgery (CABG), presented with unstable angina. Cardiac catheterization showed left main and triple-vessel disease. The saphenous vein graft (SVG) to the right coronary artery was diseased but patent, and the SVG to the left anterior descending artery (LAD) was occluded. Preoperative evaluation showed a heavily calcified ascending aorta and minimum disease on the descending aorta. He successfully underwent a left thoracotomy 2-vessel off-pump CABG using the descending aorta for the proximal anastomosis. The left thoracotomy approach is a useful alternative to avoid complications associated with resternotomy, especially in patients with a hostile chest, although visualization of the target vessels may be limited.


The Annals of Thoracic Surgery | 2017

Clinical Significance of Spontaneous Echo Contrast on Extracorporeal Membrane Oxygenation

Shinya Unai; My-Le Nguyen; Daizo Tanaka; Nataliya Gorbachuk; Gregary D. Marhefka; Hitoshi Hirose; Nicholas C. Cavarocchi

Collaboration


Dive into the Shinya Unai's collaboration.

Top Co-Authors

Avatar

Hitoshi Hirose

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daizo Tanaka

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

James T. Diehl

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Gary Cook

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

John W. Entwistle

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Qiong Yang

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harrsion Pitcher

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Joseph Miessau

Thomas Jefferson University

View shared research outputs
Researchain Logo
Decentralizing Knowledge